1[1]Huber BE,Richards CA,Kreniky TA.Retroviral-medisted gene therapy for the treatment of hepetocullar carcinoma:an innovative approach for cancer therapy[J].J Proe Nail Aced Sci USA,1991,88(18):8039-8043.
2[2]McMasters RA,Saylors RL,Jones KE,et al.Lack of bystander Killing in the herpes simplex virus thymidine Kinuse-traneducod colon cell lines due to deficient conrmxin 43 gap junction formation[J].Hum Gene Ther,1998,9(15):2253-2261.
3[3]Degreve B,De Clercq E,Balzarini J.Bystander effect of purine nucleoside analogues in HSV-1 tk suicide germ therapy is superior to that of pyrimidine nucleoside analogues[J].Gene Ther,1999,6(2):162-170.
4[4]Ramnesh R,Marr AJ,Munshi A,et al.Invivoanalysis of "bystander effcet":a cytokine eascade[J].ExpHm-atol,1996,24(7):829-838.
5[5]Mesnil M,Yamasaki K Bystander effect in herpes simplex virus-thymidine kinase/gancicloVir cancer gene therapy:role of gap-junctlonal intercellular communication[J].Cancer Res,2000,60(15):3989-3999.
6[6]Gressin I,Charissoux JI,Teissier MP,et al.Selective killing of osteosarcoma cells in culture after retroviral mediated germ transfer of a herpes simplex thymidine kinase suicide gene[J].Anticancer Res,1999,19(1A):71-76.
7[7]Charissoux JI,Groesin L,Leboutet MJ,et al.Treatment of experimental esteosarcoma tumors in rat by herpes simplex thymidine kinase germ transfer and ganciclovire[J].Anticancer Res,1999,19(1A):77-80.
